102
Participants
Start Date
November 30, 1998
oregovomab
Fox Chase Cancer Center, Philadelphia
Mercy Medical Center, Inc., Baltimore
Cancer Center, University of Virginia HSC, Charlottesville
Riverside Regional Medical Center, Newport News
Palmetto Richland Memorial Hospital, Columbia
Walt Disney Memorial Cancer Institute, Orlando
H. Lee Moffitt Cancer Center and Research Institute, Tampa
Lee Memorial Health System, Fort Myers
University of Iowa Hospitals and Clinics, Iowa City
Barnes-Jewish Hospital, St Louis
St. John's Mercy Medical Center, St Louis
University of Oklahoma College of Medicine, Oklahoma City
Texas Oncology, P.A., Dallas
Gynecologic Oncology Associates, Newport Beach
Indiana University Cancer Center, Indianapolis
Ottawa Regional Cancer Center - General Division, Ottawa
Lead Sponsor
AltaRex
INDUSTRY